Clinical Trial

To Study and Explore the Predictive Effect of Insulin Resistance-related Indicators on In-stent Restenosis After Coronary Stent Implantation

Completed
View on ClinicalTrials.gov →
Summary
Based on previous studies on insulin resistance and cardiovascular diseases, we believe that the insulin resistance metabolic score also has certain predictive value for the prognosis of in-stent restenosis after coronary stent implantation. The main purpose of this study is to explore the predictive effect of the insulin resistance metabolic score on in-stent restenosis after coronary stent implantation and to discuss a reasonable control level.
Trial Details
NCT Number NCT07614763
Lead Sponsor Qilu Hospital of Shandong University
Conditions Coronary Artery Disease, In-stent Restenosis
Enrollment 1,000 participants
Start Date 2022-01-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-29